Cargando…
Ganaxolone: A New Treatment for CDKL5 Deficiency Disorder
Autor principal: | Vossler, David G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9661611/ https://www.ncbi.nlm.nih.gov/pubmed/36426195 http://dx.doi.org/10.1177/15357597221125238 |
Ejemplares similares
-
Reigning in Excitatory Signaling in CDKL5 Deficiency
por: Forcelli, Patrick A.
Publicado: (2019) -
Diagnostic Yield and Treatment Changes After Genetic Testing of Adults With
Epilepsy
por: Vossler, David G.
Publicado: (2022) -
Can a Mouse Help Us Unravel the Mysteries of CDKL5-Related Epilepsy?
por: Goldman, Alica M.
Publicado: (2022) -
Is it a Tie at This Point in the Game? Efficacy of Levetiracetam and Phenytoin for the Second-Line Treatment of Convulsive Status Epilepticus
por: Vossler, David G.
Publicado: (2019) -
Stroke and Ischemic Heart Disease With Enzyme-inducing Antiseizure Medications: Time to Change Prescribing Habits
por: Vossler, David G.
Publicado: (2022)